多重用药与膝骨关节炎患者体力活动的关系
该横断面研究基于骨关节炎倡议(OAI)48个月随访数据,纳入1,889名有有效加速度计监测数据的膝骨关节炎参与者,评估处方药数量与每周中高强度体力活动(MVPA)分钟数的关联。结果显示多重用药(≥5种处方药)患病率为28.2%,每增加一种处方药与中位每周MVPA减少3.6分钟相关,符合多重用药标准者中位每周MVPA减少12.6分钟。
要点
- 每增加一种处方药,中位每周MVPA减少3.6分钟(95%CI -4.8至-2.1)。
- 多重用药者较非多重用药者中位每周MVPA减少12.6分钟(95%CI -21.2至-4.7)。
- 研究为横断面设计,不能确立多重用药与MVPA下降的因果关系。
核心结论
- 在膝骨关节炎成人中,处方药数量增加及多重用药与客观测量的中位每周MVPA减少呈横断面关联。
研究设计与样本
- 采用分层中位数分位数回归分析,横断面评估过去30天处方药数量与客观测量中位每周MVPA分钟数的关联,并控制人口学和临床变量。
- 数据来自美国四个OAI招募中心(普罗维登斯、哥伦布、巴尔的摩、匹兹堡),采集于48个月随访(2008-2010年)。
- 共2,127名OAI参与者接受加速度计监测,其中1,889名有4天及以上有效体力活动监测数据及完整药物/协变量数据。
主要发现
- 研究人群中多重用药(≥5种处方药)患病率为28.2%。
- 每增加一种处方药与中位每周MVPA分钟数减少3.6分钟相关(95%CI -4.8至-2.1)。
- 符合多重用药标准者较不符合者中位每周MVPA分钟数减少12.6分钟(95%CI -21.2至-4.7)。
关键数值与推荐
- 多重用药定义为服用5种及以上处方药。
- 结局为加速度计测量的每周MVPA分钟数。
- 协变量包括年龄、性别、种族/民族、体重指数、合并症、疼痛、抑郁症状及影像学膝骨关节炎严重程度。
临床怎么用
- 对膝骨关节炎老年患者应关注处方药数量,多重用药可能伴随体力活动水平下降。
- 评估多重用药时可考虑同时了解患者每周MVPA情况,但需注意横断面关联不能推断因果。
局限性
- 研究为横断面设计,无法确立多重用药与MVPA减少之间的因果关系。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Physical activity is associated with improved pain, functional status, and less disability in persons with knee osteoarthritis (KOA). Because polypharmacy is related to several adverse health outcomes in older persons, we hypothesized that it might also be associated with decreased physical activity in those with KOA. This study evaluates the relationship between the number of prescription medications and weekly moderate to vigorous physical activity (MVPA). DESIGN: We used hierarchical median quantile regression analysis to examine the cross-sectional association between the number of prescription medications taken in the past 30 days and the median objectively measured MVPA minutes controlling for demographic and clinical variables. SETTING: Four Osteoarthritis Initiative (OAI) recruitment centers in Providence, Rhode Island; Columbus, Ohio; Baltimore, Maryland; and Pittsburgh, Pennsylvania. PARTICIPANTS: Accelerometer monitoring occurred in 2,127 OAI participants. Of these, 1,889 participants had 4 or more days of valid physical activity monitoring data and complete medication/covariate data. Data were collected at the 48-month OAI follow-up visit (2008-2010). MEASUREMENTS: The outcome was weekly minutes of MVPA measured with an accelerometer. Number/type of prescribed medications and covariate data (age, sex, race/ethnicity, body mass index, presence of comorbidities, pain, depressive symptoms, and radiographic KOA severity) were taken from the public OAI database. Polypharmacy was defined as taking five or more prescribed medications. RESULTS: The prevalence of polypharmacy in the study population was 28.2%. Each additional prescription medication was related to a decrease of 3.6 minutes (95% confidence interval [CI] = -4.8 to -2.1) in median weekly MVPA minutes. Participants meeting the polypharmacy criterion exhibited a decrease of 12.6 minutes (95% CI = -21.2 to -4.7) in median weekly MVPA minutes compared with those not meeting the criterion. CONCLUSION: An increased number of prescription medications and polypharmacy are associated cross-sectionally with decreased MVPA in adults with KOA. Further study is necessary to establish the causal nature of this association.
引用
- Thanoo N, Gilbert AL, Trainor S, et al. The Relationship between Polypharmacy and Physical Activity in Those with or at Risk of Knee Osteoarthritis. J Am Geriatr Soc. 2020. PMID: 32441333. doi:10.1111/jgs.16501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。